CDMO solutions for high potent and cytotoxic drug product up to OEB 6
Today’s pharmaceutical innovations are more complex than ever. New molecules, advanced dosage forms and increasingly demanding regulatory requirements create significant challenges throughout development and manufacturing.
At QPharma, complexity is where our expertise creates the greatest value. Building on decades of expertise in polymer-based drug delivery, we combine scientific excellence, advanced delivery technologies and integrated development and manufacturing capabilities to help customers bring complex therapies to life, from early concept to commercial supply. We specialize in controlled and extended-release dosage forms, highly potent compounds up to OEB 6, and hormonal and DEA controlled substances (Schedule 3–5).